Elevated High-Sensitivity C-Reactive Protein And Interleukin-6 Plasma As Risk Factors For Symptomatic Lumbar Osteoarthritis In Postmenopausal Women

Authors

  • I Ketut Suyasa Department of Orthopaedic and Traumatology, Faculty of Medicine Udayana University, Sanglah General Hospital, Bali, Indonesia
  • Anak Agung Wiradewi Lestari Clinical Pathology, Faculty of Medicine Udayana University, Sanglah General Hospital, Bali, Indonesia
  • I Gusti Ngurah Yudhi Setiawan Department of Neurosurgery, Faculty of Medicine Udayana University, Sanglah General Hospital, Bali, Indonesia
  • Tjokorda Gde Bagus Mahadewa Department of Neurosurgery, Faculty of Medicine Udayana University, Sanglah General Hospital, Bali, Indonesia
  • I Putu Eka Widyadharma Department of Neurology, Faculty of Medicine Udayana University, Sanglah General Hospital, Bali, Indonesia http://orcid.org/0000-0002-4554-0348

DOI:

https://doi.org/10.3889/oamjms.2018.422

Keywords:

low back pain, hs-CRP, ESR, IL-6

Abstract

AIM: To determine whether elevated high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), and erythrocyte sedimentation rate (ESR), as risk factors of symptomatic lumbar osteoarthritis (OA) in estrogen deficiency postmenopausal women.

METHODS: A case-control study was conducted between January and June 2017. The inclusion criteria include post-menopausal women with estrogen deficiency with low back pain. Exclusion criteria were: patients with a history of undergoing bilateral oophorectomy, taking hormonal replacement therapy or corticosteroid, malignancies, and lumbosacral spine trauma. The blood examinations were taken to measure IL-6 level by ELISA, hs-CRP level by spectrophotometry and ESR by modified Westergren method.

RESULTS: A group of 44 pairs of subjects were divided equally into case and control groups showed that in estrogen deficiency postmenopausal women, an increased level of hs-CRP increased the risk for symptomatic lumbar OA (OR = 2.83, CI95% = 1.065-8.776, p = 0.034). Also, a high level of IL-6 increased the risk of symptomatic lumbar OA (OR = 2.7, CI95% = 0.991-8.320, p = 0.033). No such significant findings were found for an increased ESR level.

CONCLUSION: Elevated level of plasma hs-CRP and IL-6 were concluded as risk factors for symptomatic lumbar OA in post-menopausal women.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Richette P, Corvol M, Bardin T. Estrogen, cartilage, and osteoarthritis. Joint Bone Spine. 2003; 70(4):257-62. https://doi.org/10.1016/S1297-319X(03)00067-8

Suyasa IK, Kawiyana IKS, Bakta IM, Widiana IGR. Interleukin-6 and ratio of plasma interleukin-6/interleukin-10 as risk factors of symptomatic lumbar osteoarthritis. World Journal of Orthopedics. 2017; 8(2):149-155. https://doi.org/10.5312/wjo.v8.i2.149 PMid:28251065 PMCid:PMC5314144

Fujiwara A, Lim T-H, An HS, et al. The Effect of Disc Degeneration and Facet Joint Osteoarthritis on the Segmental Flexibility of the Lumbar Spine. Spine. 2000; 25(23):3036-3044. https://doi.org/10.1097/00007632-200012010-00011 PMid:11145815

Sniekers YH, Weinans H, van Osch GJ, van Leeuwen JP. Oestrogen is important for maintenance of cartilage and subchondral bone in a murine model of knee osteoarthritis. Arthritis Research & Therapy. 2010; 12(5): R182. https://doi.org/10.1186/ar3148 PMid:20923566 PMCid:PMC2991014

Wluka AE, Cicuttini FM, Spector TD. Menopause, estrogen, and arthritis. Maturitas. 2000; 30:183-99. https://doi.org/10.1016/S0378-5122(00)00118-3

Park CH, Lee SH. Investigation of High-Sensitivity C-reactive Protein and Erythrocyte Sedimentation Rate in Low Back Pain Patients. The Korean Journal of Pain. 2010; 23(2):147. https://doi.org/10.3344/kjp.2010.23.2.147 PMid:20556218 PMCid:PMC2886244

Macphail K. C-Reactive Protein, Chronic low back pain, diet, and lifestyle. Journal of Pain & Relief. 2014; 03(05). https://doi.org/10.4172/2167-0846.1000160

Zhang Y, Guo TM, Guo X, Wu S. Clinical diagnosis for discogenic low back pain. Int JBiol Sci. 2009; 5(7):647-58. https://doi.org/10.7150/ijbs.5.647

Xiao Y, Haynes WL, Michalek JE, Russell IJ. Elevated serum high-sensitivity C-reactive protein levels in fibromyalgia syndrome patients correlate with body mass index, interleukin-6, interleukin-8, erythrocyte sedimentation rate. Rheumatology International. 2012; 33(5):1259-1264. https://doi.org/10.1007/s00296-012-2538-6 PMid:23124693

Livshits G, Zhai G, Hart DJ, et al. Interleukin-6 is a significant predictor of radiographic knee osteoarthritis. Arthritis Rheum. 2009; 60(7):2037-45. https://doi.org/10.1002/art.24598 PMid:19565477 PMCid:PMC2841820

Suyasa I, Setiawan I. The role of ageing, body mass index and estrogen on symptomatic lumbar osteoarthritis in post-menopausal women. International Journal of Research in Medical Sciences. 2016:1325-1328.

Conrozier T, Saxne T, Fan CSS, et al. Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: A one-year prospective study. Annals of the Rheumatic Diseases. 1998; 57(9):527-532. https://doi.org/10.1136/ard.57.9.527 PMid:9849311 PMCid:PMC1752738

Stannus OP, Jones G, Quinn SJ, Cicuttini FM, Dore D, Ding C. The association between leptin, interleukin-6, and hip radiographic osteoarthritis in older people: a cross-sectional study. Arthritis Research & Therapy. 2010; 12(3). https://doi.org/10.1186/ar3022 PMid:20482813 PMCid:PMC2911879

Sharma P, Rahman A, Mahmood T, Singh N. Role of tumour necrosis factor alpha (TNF-α) and interleukin-6 (il-6) in postmenopausal osteoarthritic female patients. Journal of Evidence-Based Medicine and Healthcare. 2016; 3(27):1242-1244. https://doi.org/10.18410/jebmh/2016/285

Wojdasiewicz P, Poniatowski ÅA, Szukiewicz D. The Role of Inflammatory and Anti-Inflammatory Cytokines in the Pathogenesis of Osteoarthritis. Mediators of Inflammation. 2014; 2014:1-19. https://doi.org/10.1155/2014/561459 PMid:24876674 PMCid:PMC4021678

Lotz M, Guerne PA. Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA). J Biol Chem. 1991; 266(4):2017-20. PMid:1846608

Giuliani N, Sansoni P, Girasole G, et al. Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age- and menopause-related changes. Experimental Gerontology. 2001; 36(3):547-557. https://doi.org/10.1016/S0531-5565(00)00220-5

Holm S, Mackiewicz Z, Holm AK, et al. Pro-inflammatory, Pleiotropic, and Anti-inflammatory TNF-α, IL-6, and IL-10 in Experimental Porcine Intervertebral Disk Degeneration. Veterinary Pathology. 2009; 46(6):1292-1300. https://doi.org/10.1354/vp.07-VP-0179-K-FL PMid:19605905

Keller ET. Molecular and cellular biology of interleukin-6 and its receptor. Frontiers in Bioscience. 1996; 1(4):d340-357. https://doi.org/10.2741/A136 PMid:9159238

Svensson CI. Interleukin-6: a local pain trigger? Arthritis Research & Therapy. 2010; 12(5):145. https://doi.org/10.1186/ar3138 PMid:21067533 PMCid:PMC2991005

Rannou F, Ouanes W, Boutron I, et al. High-sensitivity C-reactive protein in chronic low back pain with vertebral end-platemodec signal changes. Arthritis & Rheumatism. 2007; 57(7):1311-1315. https://doi.org/10.1002/art.22985 PMid:17907216

Sugimori K, Kawaguchi Y, Morita M, Kitajima I, Kimura T. High-sensitivity analysis of serum C-reactive protein in young patients with lumbar disc herniation. The Journal of Bone and Joint Surgery British volume. 2003; 85-B(8):1151-1154. https://doi.org/10.1302/0301-620X.85B8.14538

Shimura Y, Kurosawa H, Sugawara Y, et al. The factors associated with pain severity in patients with knee osteoarthritis vary according to the radiographic disease severity: a cross-sectional study. Osteoarthritis and Cartilage. 2013; 21(9):1179-1184. https://doi.org/10.1016/j.joca.2013.05.014 PMid:23973128

Gebhardt K, Brenner H, Stürmer T, et al. The course of high-sensitive C-reactive protein in correlation with pain and clinical function in patients with acute lumbosciatic pain and chronic low back pain-Asix6 months prospective longitudinal study. European Journal of Pain. 2006; 10(8):711-711. https://doi.org/10.1016/j.ejpain.2005.11.005 PMid:16403662

Pearle A, Scanzello C, George S, et al. Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis. Osteoarthritis and Cartilage. 2007; 15(5):516-523. https://doi.org/10.1016/j.joca.2006.10.010 PMid:17157039

Sturmer T. Pain and high sensitivity C reactive protein in patients with chronic low back pain and acute sciatic pain. Annals of the Rheumatic Diseases. 2005; 64(6):921-925. https://doi.org/10.1136/ard.2004.027045 PMid:15897311 PMCid:PMC1755532

Kim OY, Chae JS, Paik JK, et al. Effects of aging and menopause on serum interleukin-6 levels and peripheral blood mononuclear cell cytokine production in healthy nonobese women. Age. 2011; 34(2):415-425. https://doi.org/10.1007/s11357-011-9244-2 PMid:21487705 PMCid:PMC3312621

Jin X, Beguerie JR, Zhang W, Blizzard L, Otahal P, Jones G, Ding C. Circulating C reactive protein in osteoarthritis: a systematic review and meta-analysis. Annals of the rheumatic diseases. 2015; 74(4):703-10. https://doi.org/10.1136/annrheumdis-2013-204494 PMid:24363360

Published

2018-11-23

How to Cite

1.
Suyasa IK, Lestari AAW, Setiawan IGNY, Mahadewa TGB, Widyadharma IPE. Elevated High-Sensitivity C-Reactive Protein And Interleukin-6 Plasma As Risk Factors For Symptomatic Lumbar Osteoarthritis In Postmenopausal Women. Open Access Maced J Med Sci [Internet]. 2018 Nov. 23 [cited 2022 May 19];6(11):2107-10. Available from: https://oamjms.eu/index.php/mjms/article/view/oamjms.2018.422

Issue

Section

B - Clinical Sciences

Most read articles by the same author(s)

1 2 3 4 > >>